Your search returned 3 results.

Results
	1.	A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study. [electronic resource] by Astermark, Jan Donfield, Sharyne M DiMichele, Donna M Gringeri, Alessandro Gilbert, Steven A Waters, Jennifer Berntorp, Erik Producer: 20070830 In: Blood vol. 109 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Safety, tolerability, pharmacokinetics, and pharmacodynamics of PF-06650833, a selective interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitor, in single and multiple ascending dose randomized phase 1 studies in healthy subjects. [electronic resource] by Danto, Spencer I Shojaee, Negin Singh, Ravi Shankar P Li, Cheryl Gilbert, Steven A Manukyan, Zorayr Kilty, Iain Producer: 20200909 In: Arthritis research & therapy vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	TYK2/JAK1 Inhibitor PF-06700841 in Patients with Plaque Psoriasis: Phase IIa, Randomized, Double-Blind, Placebo-Controlled Trial. [electronic resource] by Forman, Seth B Pariser, David M Poulin, Yves Vincent, Michael S Gilbert, Steven A Kieras, Elizabeth M Qiu, Ruolun Yu, Dahong Papacharalambous, Jocelyne Tehlirian, Christopher Peeva, Elena Producer: 20210401 In: The Journal of investigative dermatology vol. 140 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)